4-Methylmorpholine → HCID 58529272, compound

Participants

Reaction Steps

A solution of 5-(2-benzyl-2H-indazol-6-yl)-7-morpholin-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-amine (59.1 mg, 0.11 mmol) in dichloromethane (1 mL) was cooled to 0° C. and treated with 4-methylpiperazine-1-carbonyl chloride (18 mg, 0.11 mmol) and N-methylmorpholine (28 mg, 0.28 mmol). After stirring for 1 h at rt, the reaction was diluted with 1 mL MeOH and diluted with EtOAc and 1N sodium carbonate solution. The organic layer was dried with sodium sulfate and concentrated in vacuo. The residue was triturated with acetonitrile to provide 41 mg (67%) of the desired product as an off-white solid. 1H NMR (300 MHz, DMSO-d6) δ 8.55 (s, 1 H), 7.95 (d, 1 H, J=3 Hz), 7.81 (d, 1 H, J=9 Hz), 7.61 (s, 1 H), 7.27-7.40 (m, 5H), 7.14 (d, 1H, J=9 Hz), 6.81 (d, 1 H, J=4 Hz), 5.65 (s, 2 H), 5.10-5.15 (m, 1H), 4.45-4.55 (m, 1 H), 3.95-4.25 (m, 3H), 3.65-3.85 (m, 3H), 3.49-3.60 (m, 1H), 3.30 (s, 3H), 3.35-3.25 (m, 1H), 3.14-3.25 (m, 1H); ES-MS Ink 552.1 [M+H]+, HPLC RT (min) 2.21.

Provenance & Evidence